North America Drug Delivery Market - Trends and Forecast to 2024

  • ID: 4372747
  • Report
  • Region: America, North America, United States
  • 254 pages
  • Data Bridge Market Research Private Limited
1 of 5
North America Drug Delivery Market is Expected to Reach USD 823.55 Billion by 2024, at a CAGR of 6.4% During the Forecast Period of 2017 to 2024

FEATURED COMPANIES

  • 3M
  • Antares Pharma
  • Cima Labs Inc.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc.
  • Nemera
  • MORE
Synopsis:
  • North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024, at a CAGR of 6.4% during the forecast period of 2017 to 2024. The report contains 254 pages of exclusive premium insights with 165 tables and 20 figures.
  • North America Drug Delivery Market is segmented based on product type, end-user, distribution channel, and geography.
  • On the basis of route of administration the drug delivery market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal.
  • Based on distribution channel the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.
  • On the basis of end users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others.
  • The North America drug delivery market is segmented into 3 major countries such as U.S., Canada, and Mexico.
Major Players Operating in this Market: Johnson & Johnson Services, Inc., Novartis AG, F. Hoffmann-La Roche AG, Pfizer, Inc., GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Nemera, Cima Labs, Inc., Dali Medical Devices, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals DSM Biomedical and Catalent, Inc. among others.

Regions Covered in the Scope of the Report: North America (U.S., Canada and Mexico)
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M
  • Antares Pharma
  • Cima Labs Inc.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc.
  • Nemera
  • MORE
1. Introduction
1.1. Overview of North America Drug Delivery Devices Market
1.2. Currency and Pricing
1.3. Limitation
1.4. Markets Covered

2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered for the Study
2.4. Currency and Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview
3.1. Drivers
3.1.1. Rising Prevalence of Chronic Disease Such as Diabetes
3.1.2. Growth in the Development of Biologics
3.1.3. Technological Development
3.2. Restraints
3.2.1. Risk of Needle-Stick Injuries and Side Effects
3.3. Opportunities
3.3.1. Rising Acceptance of Self Administering Drugs
3.3.2. Rising Demand for Biosimilars and Generic Drugs
3.3.3. Trend of Merger and Acquisitions, and Collaborations
3.3.4. Focus on Patient Needs
3.3.5. Developing and New Emerging Revenue Pockets
3.4. Threats
3.4.1. Product Recalls
3.4.2. Stringent Regulatory and High Pricing
3.4.3. Patent Expiry and Patent Cliff

4. Executive Summary

5. Premium Insights

6. North America Drug Delivery Devices Market, by Product Type
6.1. Overview
6.2. North America Oral Drug Delivery Market, by Product Type
6.3. North America Solid Oral Drug Delivery Market,
By Product Type
6.4. North America Liquid Oral Drug Delivery Market,
By Product Type
6.5. North America Semi-Solid Oral Drug Delivery Market,
By Product Type
6.6. North America Pulmonary Drug Delivery Market,
By Product Type
6.7. North America Nebulizers Market, by Product Type
6.8. North America Injectable Drug Delivery Market,
By Product Type
6.9. North America Injectable Drug Delivery Devices,
By Product Type
6.9.1. North America Conventional Injectable Drug Delivery Devices Market
6.9.2. North America Self-Injection Drug Delivery Devices Market, by Product Type
6.10. North America Injectable Drug Delivery Formulations Market, by Product Type
6.11. North America Ophthalmic Drug Delivery Market,
By Product Type
6.12. North America Ophthalmic Drug Delivery Formulations Market,By Form
6.13. Ophthalmic Drug Delivery Devices, by Product Type
6.14. North America Nasal Drug Delivery Market, by Product Type
6.15. North America Topical Drug Delivery Market, by Product Type
6.16. North America Transdermal Drug Delivery Devices Market, by Product Type
6.17. North America Topical Drug Delivery Formulations Market, by Product Type
6.17.1. North America Semi Solid Topical Drug Delivery Formulations Market, by Type
6.17.2. North America Liquid Topical Drug Delivery Formulations Market, by Type
6.17.3. North America Solid Topical Drug Delivery Formulations Market, by Type
6.18. North America Implantable Drug Delivery Market,
By Product Type
6.19. North America Transmucosal Drug Delivery Market,
By Product Type
6.20. North America Oral Transmucosal Drug Delivery Market, by Product Type
6.21. North America Oral Transmucosal Drug Delivery Market, by Product Type

7. North America Drug Delivery Devices Market, by End User
7.1. Overview

8. North America Drug Delivery Devices Market, by Distribution Channel
8.1. Overview

9. Drug Delivery Market, by Geography
9.1. North America Drug Delivery Devices Market
9.2. U.S. Drug Delivery Devices Market
9.3. Canada Drug Delivery Devices Market
9.4. Mexico Drug Delivery Devices Market

10. North America Drug Delivery Devices Market, Company Share
10.1. Company Share Analysis: North America

11. Company Profiles
11.1. Bayer Ag
11.1.1. Company Overview
11.1.2. Revenue Analysis
11.1.3. Product Portfolio
11.1.4. Recent Developments
11.2. F. Hoffmann-La Roche Ltd
11.2.1. Company Overview
11.2.2. Revenue Analysis
11.2.3. Product Portfolio
11.2.4. Recent Developments
11.3. Glaxosmithkline Plc
11.3.1. Company Overview
11.3.2. Revenue Analysis
11.3.3. Product Portfolio
11.3.4. Recent Developments
11.4. Johnson & Johnson Services, Inc.
11.4.1. Company Overview
11.4.2. Revenue Analysis
11.4.3. Product Portfolio
11.4.4. Recent Developments
11.5. Novartis
11.5.1. Company Overview
11.5.2. Revenue Analysis
11.5.3. Product Portofolio
11.5.4. Recent Developments
11.6. Pfizer, Inc.
11.6.1. Company Overview
11.6.2. Revenue Analysis
11.6.3. Product Portfolio
11.6.4. Recent Developments
11.7. 3M
11.7.1. Company Overview
11.7.2. Revenue Analysis
11.7.3. Product Portfolio
11.7.4. Recent Developments
11.8. Antares Pharma, Inc.
11.8.1. Company Overview
11.8.2. Revenue Analysis
11.8.3. Product Portfolio
11.8.4. Recent Developments
11.9. Merck & Co.
11.9.1. Company Overview
11.9.2. Revenue Analysis
11.9.3. Product Portfolio
11.9.4. Recent Developments
11.10. Sanofi
11.10.1. Company Overview
11.10.2. Revenue Analysis
11.10.3. Product Portofolio
11.10.4. Recent Developments

12. Related Reports
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • F. Hoffmann-La Roche AG
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Merck & Co.
  • Sanofi
  • Antares Pharma
  • 3M
  • Becton Dickinson and Company
  • Nemera
  • Cima Labs Inc.
  • Dali Medical Devices
  • Alkermes
  • Foamis
  • Ypsomed
  • Skyepharma AG
  • Valeant Pharmaceuticals DSM Biomedical
  • Catalent Inc.
  • others
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll